Rasha Aboelhassan/LinkedIn
May 28, 2025, 08:47
Rasha Aboelhassan Shares Insights from EGFR Lung Cancer Meeting with Al Hussein University Oncology Team
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:
“Yesterday, I was very excited to participate in the meeting with Al Hussein University Oncology team for EGFR lung cancer meeting.
We discussed different levels of challenges in early stages as well as late stages, from screening and early detection up to financial toxicity.
The main challenge was the financial toxicity for adjuvant osimertinib three years in early NSCLC.
Anyway, I was very optimistic because we, as a team, overcome other challenges before, such as screening and early detection.
Thanks for your efforts and participation every person.”
More posts featuring Rasha Aboelhassan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 19, 2025, 16:01